ACT Capital Management »

Sentinelone shares owned by ACT Capital Management

Quarter-by-quarter ownership of Sentinelone (S) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Sentinelone

Tip: Access up to 7 years of quarterly data

All positions including Sentinelone held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sentinelone by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $699k 54k 12.88

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Celcuity (CELC)
Tg Therapeutics (TGTX)
Abivax Sa Sponsored Ads (ABVX)
Amazon (AMZN)
Viking Therapeutics (VKTX)
Arrowhead Pharmaceuticals (ARWR)
Nektar Therapeutics Com New (NKTR)
Cytokinetics (CYTK)
Alumis (ALMS)
Energy Transfer Com Ut Ltd Ptn (ET)
Freeport-McMoRan Copper & Gold (FCX)
Applied Optoelectronics (AAOI)

View all positions for ACT Capital Management

Top funds holding Sentinelone

Vanguard Group
BlackRock
Vanguard Portfolio Management
AQR Capital Management
Vanguard Capital Management
First Trust Advisors
Legal & General Group
Redpoint Management
Millennium Management
Caprock
Susquehanna International
Point72 Asset Management
Ing Investment Management
Geode Capital Management
State Street Corporation

View all funds holding Sentinelone